Welcome to our dedicated page for Idaho Strategic Resources SEC filings (Ticker: IDR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Idaho Strategic Resources filings document the public-company disclosures of a NYSE American-listed Idaho mining issuer with common stock outstanding. Form 8-K reports provide Regulation FD updates on consolidated operating and financial results, Golden Chest Mine production, gold sales economics, reserves, exploration activity, and related mining infrastructure.
Proxy and annual-meeting filings cover board elections, auditor ratification, shareholder voting results, executive and director governance matters, and the company's no-par common stock structure. The filing record also identifies the company's incorporation in Idaho and connects formal disclosures to its gold production and mineral exploration business in the Murray Gold Belt.
Kevin G. Shiell, a director of Idaho Strategic Resources, sold 6,500 common shares on 08/11/2025 at a weighted average price of $25.03 per share, with the sale prices ranging from $24.31 to $25.45. The filing states these shares were originally acquired on March 28, 2017 in a private placement.
The transaction completes the disposition of 14,286 common shares previously disclosed on Form 144. After this reported sale Mr. Shiell beneficially owned 49,016 common shares held directly. No derivative securities are reported on this Form 4.
Idaho Strategic Resources, Inc. furnished a press release on August 7, 2025 reporting its consolidated results for the quarter ended June 30, 2025. The release states the company achieved a 54.71% increase in revenue to $9,476,739, which the company calls a new quarterly revenue record, and that it completed 5,819 meters of drilling.
The press release is attached as Exhibit 99.1 to this Form 8-K and is furnished under Regulation FD (it is not being "filed" for Section 18 purposes). The Form 8-K itself does not include additional financial statements or detailed line-item results in the body of the filing.
Idaho Strategic Resources (IDR) – Form 4 insider activity
Director Kevin G. Shiell executed two cashless option exercises on 18-Jul-2025. He exercised 3,000 options at $5.25 and 7,500 options at $4.75. To fund the exercises, the issuer retained 874 and 1,977 shares, respectively, valued at the prevailing market price of $18.02. Net result: 7,649 common shares were added to Shiell’s direct holdings, which now total 55,516 shares. Derivative holdings fell from 17,500 to 10,000 options as the 10,500 options exercised were removed.
No sale of newly issued shares occurred on the open market; the disposals represent shares withheld for exercise costs. The transactions increase the director’s equity stake and reduce potential option overhang, but do not affect the company’s financial results.
Form 4 filing: Idaho Strategic Resources (IDR) President & CEO John Swallow reported the sale of 100,000 common shares on 07/10/2025 at $15.27 per share, for gross proceeds of roughly $1.53 million. After the transaction, Swallow still owns 830,248 shares directly. The filing notes that the sale completes the disposition previously disclosed on a Form 144 dated July 10, 2025. No derivative securities were exercised or granted, and no other insider transactions were listed.
The document contains no financial performance data or additional strategic disclosures; it strictly records this single insider transaction.
Idaho Strategic Resources, Inc. (IDR) – Form 144 filing discloses a proposed insider sale of 12,724 common shares through broker D.A. Davidson & Co. The shares represent roughly 0.09 % of the 14.06 million shares outstanding and have an aggregate market value of $195,467 (≈ $15.37 per share).
• 11,224 shares were acquired on 05/14/2024 via cash exercise of stock options granted on 02/11/2021 and 10/20/2021.
• 1,500 shares were purchased on the open market on 02/20/2020.
No sales were reported over the past three months, and the anticipated sale date is 07/10/2025 on the NYSE American.
The filing contains no indication of material adverse information and confirms compliance with Rule 144 conditions. Given the small percentage of shares involved, the transaction is unlikely to be market-moving, but investors may interpret it as a routine liquidity event or mild negative sentiment from the insider.